Novel heteroarotinoids: synthesis and biological activity

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Retinoids are crucial signaling molecules with therapeutic applications.
• Developing novel retinoids with improved efficacy and specificity is an ongoing research area.
• Heterocyclic compounds offer unique structural scaffolds for drug discovery.

Purpose of the Study:

• To synthesize and characterize a series of novel heteroarotinoids.
• To evaluate the biological activity of these compounds in two key assays: ornithine decarboxylase (ODC) inhibition and HL-60 cell differentiation.
• To identify structure-activity relationships for enhanced retinoid activity.

Main Methods:

• Synthesis of 13 heteroarotinoids via condensation of phosphorus ylides with polyene-substituted aldehyde esters.
• Screening using an assay for inhibition of phorbol ester-induced mouse epidermal ornithine decarboxylase (ODC) activity.
• Screening using an assay for retinoid-induced differentiation of human myeloid leukemia cell line HL-60.

Main Results:

• Compounds 10 (ester) and 11 (acid) demonstrated potent ODC inhibition (ID50 ≈ 0.3 nmol), comparable to trans-retinoic acid (ID50 = 0.12 nmol).
• The presence of a thiochroman unit and a benzoic acid/ester terminal group enhanced ODC inhibitory activity.
• Structural modifications, such as replacing a propenyl system with a cyclopropyl group, led to markedly reduced activity.

Conclusions:

• Novel heteroarotinoids, particularly those incorporating thiochroman and benzoic acid moieties, exhibit significant retinoid-like biological activity.
• These findings highlight the potential of these synthesized compounds as leads for further drug development.
• The study establishes structure-activity relationships guiding the design of future retinoid analogs.